The Food and Drug Administration said Thursday that it will sharply limit access to the anti- diabetes drug Avandia because of concerns about an increased cardiovascular risk associated with the drug.
Patients who are now taking the drug will have to sign an informed consent statement acknowledging that they understand all the risks before they will be allowed to continue refilling prescriptions.
FDA to limit access to diabetes drug Avandia
A provision in last year’s One Big Beautiful Bill Act blocked Planned Parenthood’s health centers from...
The U.S. Department of Agriculture confirmed the presence of New World screwworm in a 3-week-old calf...
A smart drug that stops cancer cells “hiding” from treatment can shrink tumours by at least...
